Adequan Canine Injection (5 ml)

Adequan Canine (polysulfated glycosaminoglycan) is the only FDA-approved disease-modifying osteoarthritis drug (DMOAD) that inhibits cartilage loss in the dog’s joints, and may help to:¹

Key Benefits

• Restore joint lubrication
• Relieve inflammation
• Renew the building blocks of healthy cartilage

That’s what makes Adequan® Canine different from a supplement or NSAID. It proactively treats the disease and not just the signs of canine osteoarthritis.¹

The specific mechanism of action of Adequan® in canine joints is not known.¹

How It Works

Binds to components of the cartilage matrix to help prevent further degradation of the joints.

• Reduces inflammation and decreases pain.
• Inhibits release of degradative enzymes and inflammatory mediators to help restore balance.
• Stimulates the activity of existing cartilage components and improves synovial fluid to help renew joint mobility.

Indications

Adequan® Canine is recommended for intramuscular injection for the control of signs associated with non-infectious degenerative and/or traumatic arthritis of canine synovial joints.

Other Ingredients:

Sodium hydroxide and/or hydrochloric acid added when necessary to adjust pH. Sodium Chloride may be added to adjust tonicity.

View Adequan Drug Facts Sheet.

Practice aseptic techniques in withdrawing each dose todecrease the possibility of post-injection bacterial infections. Adequately clean anddisinfect the stopper prior to entry with a sterile needle and syringe. Use only sterileneedles, and use each needle only once.

The vial stopper may be punctured a maximum of 10 times.

The recommended dose of Adequan® Canine is 2 mg/lb body weight (.02 mL/lb, or 1 mL per50 lb), by intramuscular injection only, twice we